Granules India Limited

Granules Net Profit Up 28% in Q3 to ₹150 Crore, Driven by Strong FD Sales in North America and Europe

Granules India has reported a significant rise in its net profit, posting ₹150.2 crore for the third quarter ended December 2025, marking a 28% jump from ₹117.6 crore recorded a year earlier. The growth highlights the company’s steady execution of its strategic initiatives and solid performance a...

Adani Total Gas, Aditya Birla Fashion, SJVN Among 8 Stocks to Exit NSE’s F&O Segment from August 29

The futures and options (F&O) space on the National Stock Exchange (NSE) is about to see a reshuffle. With the September F&O series beginning Friday, August 29, eight well-known stocks—including Adani Total Gas, Aditya Birla Fashion, and SJVN—will no longer be available in the derivatives...

Alkem Laboratories and PN Gadgil Jewellers Share Price Jump on Strong Q1 FY26 Results

Mumbai, August 12 – Shares of Alkem Laboratories and PN Gadgil Jewellers witnessed a sharp rally on Tuesday after both companies posted robust earnings for the April–June quarter of FY26. The positive financial performance boosted investor sentiment, driving notable gains in the stock market.Mark...

Pharma Stocks Plunge: Sun Pharma, Aurobindo, Cipla, Lupin Fall as Trump Cracks Down on Global Drug Prices

Market PerformancePharma stocks witnessed a sharp sell-off on Friday, triggered by new developments from the United States that rattled investor sentiment.The Nifty Pharma index fell over 2.8%, marking its third consecutive day of decline.Sun Pharma led the fall with a 4% drop, becoming the worst...

Pharma Stocks Slide: Aurobindo Pharma, Lupin, Dr Reddy’s, and Others See Sharp Decline Amid Tariff Concerns

Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...

Granules India Share Price Falls After USFDA Issues Observation to Hyderabad Facility

Market PerformanceGranules India's share price experienced a dip in early trading on June 23, 2025, following a regulatory update regarding its facility in Hyderabad.Current Price: ₹483.45Change: Down by ₹3.40 or 0.70% on the BSEMarket Cap: ₹11,730.61 Crore52-week High: ₹724.55 (as of September 2...